Supporting A Young Patient with Critical Needs in Ukraine

Introduction

At OXIMIO, our core values of care and commitment extend far beyond business – they define who we are and our mission to serve and support communities worldwide. As a leading supply chain solutions provider for clinical trials, we are dedicated to facilitating patient access to life-saving treatments. In this case study we illustrate how our team in Ukraine responded to a unique and urgent request for support, ensuring the timely importation and delivery of essential medical kits to a child suffering from spinal muscular atrophy (SMA).

Requirement

The situation began when a patient support organisation reached out to OXIMIO for assistance. The organisation was working with a child in Ukraine who had been enrolled in a 2017 multi-centre study led by a European multinational healthcare company. This study had been set up to investigate a treatment for infants with SMA Type 1, a rare and debilitating condition.

While the clinical trial had concluded, the pharmaceutical company made a five-year commitment to continue providing the child with vital medical supplies. The challenge, however, arose when the patient support organisation encountered significant logistical and regulatory obstacles in importing and delivering these life-sustaining kits. The absence of a registered post-trial programme in Ukraine complicated the process, leaving the organisation in need of a trusted partner who could navigate these complexities.

Solution

OXIMIO was uniquely positioned to address this challenge, thanks to our extensive expertise and international presence in the supply chain sector for clinical trials. Our teams in Ukraine, Hungary, and CARE collaborated closely to develop a tailored solution that identified and leveraged alternative, compliant legal pathways to address regulatory complexities and ensure the timely delivery of the required medical kits.

This success reflects the strong coordination and shared commitment of our cross-country and cross-functional teams, who worked together to design and implement a unified strategy that addressed both logistical and regulatory complexities. It included:

• Coordinating with local authorities to understand the specific regulatory requirements.

• Managing international logistics across multiple countries to facilitate the safe and efficient transport of the medical kits.
• Providing updates and continuous communication with the patient support organisation to ensure transparency and minimise any delays.

This collaborative approach allowed us to address the logistical and regulatory challenges swiftly and successfully, ensuring that the child received the necessary medical kits without disruption.

Outcome and Impact

The successful delivery of the medical kits was a testament to the power of cross-border collaboration and our ability to respond swiftly to urgent, life-changing needs. By overcoming logistical challenges and ensuring the timely importation of essential supplies, we not only supported the continuation of the child’s treatment but also reinforced our commitment to being more than just a service provider.

This initiative demonstrated our dedication to making a tangible impact on patients’ lives, especially in critical situations where time is of the essence.

Conclusion

At OXIMIO, our core values of care and commitment guide every decision we make, and this case study exemplifies our dedication to supporting patients in their most vulnerable moments. We extend our heartfelt gratitude to the patient support organisation for their trust and collaboration. Moreover, we commend our teams for their dedication, expertise, and seamless coordination across borders.

Supply Chain Solutions for Clinical Trials

To find out how we can support your clinical trial, why not explore our website to explore our supply chain solutions across logistics, patient care and comparator sourcing.